Related Experiment Video
Updated: Apr 6, 2026

Two- and Three-Dimensional Live Cell Imaging of DNA Damage Response Proteins
Published on: September 28, 2012
Monitoring the Activation of the DNA Damage Response Pathway in a 3D Spheroid Model
Odile Mondesert1, Céline Frongia1, Olivia Clayton1
1Université de Toulouse; ITAV-USR3505, F-31106 Toulouse, France; CNRS; ITAV-USR3505, F-31106 Toulouse, France.
Abstract:
Monitoring the DNA-Damage Response (DDR) activated pathway in multicellular tumor spheroid models is an important challenge as these 3D models have demonstrated their major relevance in pharmacological evaluation. Herein we present DDR-Act-FP, a fluorescent biosensor that allows detection of DDR activation through monitoring of the p21 promoter p53-dependent activation. We show that cells expressing the DDR-Act-FP biosensor efficiently report activation of the DDR pathway after DNA damage and its pharmacological manipulation using ATM kinase inhibitors. We also report the successful use of this assay to screen a small compound library in order to identify activators of the DDR response. Finally, using multicellular spheroids expressing the DDR-Act-FP we demonstrate that DDR activation and its pharmacological manipulation with inhibitory and activatory compounds can be efficiently monitored in live 3D spheroid model. This study paves the way for the development of innovative screening and preclinical evaluation assays.
Insights
A new fluorescent biosensor, DDR-Act-FP, enables monitoring of the DNA-Damage Response (DDR) pathway in 3D tumor models. This tool aids in drug screening and preclinical evaluation by tracking DDR activation in live spheroids.
Area of Science:
- Biochemistry
- Molecular Biology
- Cancer Research
Background:
- Multicellular tumor spheroids (3D models) are crucial for pharmacological evaluation.
- Monitoring the DNA-Damage Response (DDR) pathway in these models presents a significant challenge.
Purpose of the Study:
- To develop a fluorescent biosensor for detecting DDR activation in 3D tumor models.
- To enable monitoring of p53-dependent p21 promoter activation as a readout for DDR.
Main Methods:
- Development and application of the DDR-Act-FP fluorescent biosensor.
- Utilizing ATM kinase inhibitors for pharmacological manipulation of DDR.
- Screening a small compound library to identify DDR activators.
- Live monitoring of DDR activation in multicellular spheroids.
Main Results:
- DDR-Act-FP efficiently reports DDR pathway activation upon DNA damage and drug treatment.
- The biosensor successfully identified activators of the DDR response from a compound library.
- Live monitoring of DDR activation and its modulation was achieved in 3D spheroid models.
Conclusions:
- DDR-Act-FP is a valuable tool for monitoring DDR in 3D tumor models.
- This biosensor facilitates innovative screening and preclinical evaluation assays.
- The study demonstrates the potential for live monitoring of DDR in complex 3D environments.
Related Concept Videos
DNA Damage Can Stall the Cell Cycle
DNA Damage can Stall the Cell Cycle
Nucleotide Excision Repair
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Nucleotide Excision Repair
Overview of DNA Repair
Chemically...

